Viral Kansara
- Molecular Biology
- Ophthalmology top 2%
- Radiology, Nuclear Medicine and Imaging top 10%
- Pharmaceutical Science top 5%
- Oncology
- Co-authors
- Thomas A. CiullaSoumyajit MajumdarKetan HippalgaonkarAshim K. MitraShuanghui LuoDhananjay PalRehan M. HussainAlon Harris
- Topics
- Retinal Diseases and Treatments (13 papers)Retinal Development and Disorders (11 papers)Glaucoma and retinal disorders (6 papers)
- Journals
- Journal of Controlled ReleaseInternational Journal of PharmaceuticsJournal of Pharmaceutical Sciences
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Viral Kansara
30 papers receiving 815 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 391
- Ophthalmology 324
- Radiology, Nuclear Medicine and Imaging 176
- Pharmaceutical Science 125
- Oncology 99
Countries citing papers authored by Viral Kansara
This map shows the geographic impact of Viral Kansara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viral Kansara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viral Kansara more than expected).
Fields of papers citing papers by Viral Kansara
This network shows the impact of papers produced by Viral Kansara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viral Kansara. The network helps show where Viral Kansara may publish in the future.
Co-authorship network of co-authors of Viral Kansara
This figure shows the co-authorship network connecting the top 25 collaborators of Viral Kansara. A scholar is included among the top collaborators of Viral Kansara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viral Kansara. Viral Kansara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 17 | |
| 3 | Suprachoroidally delivered DNA nanoparticles produce human Myosin7A protein in RPE-choroid in rabbits | 1 |
| 4 | Long-acting potential of suprachoroidally delivered BCX4161, a selective plasma kallikrein inhibitor, for diabetic macular edema | 5 |
| 5 | Pharmacokinetics and Ocular Tolerability of Suprachoroidal CLS-AX (axitinib injectable suspension) in rabbits | 8 |
| 6 | Ocular Pharmacokinetics and Safety of Suprachoroidal A01017, Small Molecule Complement Inhibitor, Injectable Suspension in Rabbits | 8 |
| 7 | 56 | |
| 8 | Suprachoroidally delivered non-viral DNA nanoparticles transfect chorioretinal cells in non-human primates and rabbits | 4 |
| 9 | 12 | |
| 10 | 18 | |
| 11 | 14 | |
| 12 | 176 | |
| 13 | 30 | |
| 14 | 22 | |
| 15 | 26 | |
| 16 | 18 | |
| 17 | 20 | |
| 18 | 26 | |
| 19 | 51 | |
| 20 | 19 |
About Viral Kansara
Viral Kansara is a scholar working on Ophthalmology, Physiology and Molecular Biology, having authored 30 papers that have together received 864 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (13 papers), Retinal Development and Disorders (11 papers) and Glaucoma and retinal disorders (6 papers). The work is most often cited by research in Ophthalmology (324 citations), Pharmaceutical Science (125 citations) and Radiology, Nuclear Medicine and Imaging (176 citations). Viral Kansara has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Thomas A. Ciulla, Soumyajit Majumdar, Ketan Hippalgaonkar, Ashim K. Mitra, Shuanghui Luo, Dhananjay Pal, Ashim K. Mitra, Rehan M. Hussain, Alon Harris and Ritesh Jain. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.